Related Experiment Video
Updated: Jan 21, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Abstract:
The novel drug SM-88 seems to be a promising therapy for previously treated patients with advanced pancreatic ductal adenocarcinoma. In a phase II trial, the modified dysfunctional tyrosine derivative was well tolerated and elicited responses or led to stable disease in 44% of patients.
Insights
A novel drug, SM-88, shows promise for advanced pancreatic cancer patients. In a phase II trial, it was well-tolerated and effective in 44% of participants.
Area of Science:
- Oncology
- Drug Development
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a challenging cancer with limited treatment options.
- SM-88 is a novel, modified dysfunctional tyrosine derivative investigated for cancer therapy.
Discussion:
- The phase II trial evaluated SM-88 in patients with previously treated advanced PDAC.
- The study assessed the safety and efficacy of SM-88 in this patient population.
Key Insights:
- SM-88 was well-tolerated in patients with advanced pancreatic cancer.
- A significant percentage of patients (44%) experienced a response or stable disease.
Outlook:
- These findings suggest SM-88 as a potential therapeutic option for advanced PDAC.
- Further clinical trials are warranted to confirm the efficacy and safety of SM-88.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

